News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Chrousos Phaedra
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/12/2023 |
4
| Chrousos Phaedra (Director) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Granted 17,307 shares
@ $0
Granted 33,960 options to buy
@ $6.5, valued at
$220.7k
|
|
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2021 |
4
| Chrousos Phaedra (Director) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Sold 2,075 shares
@ $19.3408, valued at
$40.1k
|
|
| 06/14/2021 |
4
| Chrousos Phaedra (Director) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Granted 5,000 shares
@ $0
Granted 10,000 options to buy
@ $19.21, valued at
$192.1k
|
|
| 06/15/2020 |
4
| Chrousos Phaedra (Director) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Granted 5,000 shares
@ $0
Granted 10,000 options to buy
@ $10.57, valued at
$105.7k
|
|
| 06/17/2019 |
4
| Chrousos Phaedra (Director) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Granted 5,000 shares
@ $0
Granted 10,000 options to buy
@ $15.04, valued at
$150.4k
|
|
| 04/24/2019 |
4
| Chrousos Phaedra (Director) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Granted 35,000 options to buy
@ $17.31, valued at
$605.9k
|
|
|
|